title: Cancer metabolism as a therapeutic target: metabolic synthetic lethality.
authors.affiliation: CRUK Growth Factor Group, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; and John Radcliffe Hospital, Headington, Oxford.
authors.forename: Karim
authors.initials: K
authors.lastname: Bensaad
authors.forename: Adrian L
authors.initials: AL
authors.lastname: Harris
mesh_terms: D006019:Glycolysis / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*